Flurbiprofen and hypertension but not hydroxyethyl starch are associated with post-craniotomy intracranial haematoma requiring surgery

British Journal of Anaesthesia

Volumn 113, Issue 5, 2014, Pages 832-839

  Jian, M ^a   Li, X ^a   Wang, A ^a   Zhang, L ^b   Han, R ^a   Gelb, A W ^c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

flurbiprofen; hydroxyethyl starch; hypertension; postoperative haemorrhage

Indexed keywords

FLURBIPROFEN; HETASTARCH; BLOOD SUBSTITUTE; HETASTARCH DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; BRAIN HEMATOMA; CONTROLLED STUDY; CRANIOTOMY; DISEASE ASSOCIATION; FEMALE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HYPERTENSION; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; POST CRANIOTOMY INTRACRANIAL HEMATOMA; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; SURGICAL RISK; SYSTOLIC BLOOD PRESSURE; ADOLESCENT; BLOOD PRESSURE; CASE CONTROL STUDY; COMPLICATION; INTRACRANIAL HEMORRHAGES; MIDDLE AGED; NEUROSURGERY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD PRESSURE; BLOOD SUBSTITUTES; CASE-CONTROL STUDIES; CRANIOTOMY; FEMALE; FLURBIPROFEN; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; HYPERTENSION; INTRACRANIAL HEMORRHAGES; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; POSTOPERATIVE HEMORRHAGE; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84911096224     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aeu185     Document Type: Article

References (36)

1. Elliott J, Smith M. The acute management of intracerebral hemorrhage: a clinical review. Anesth Analg 2010; 110: 1419-27
2. Seifman MA, Lewis PM, Rosenfeld JV,Hwang PY. Postoperative intracranial haemorrhage: a review. Neurosurg Rev 2011; 34: 393-407
3. Palmer JD, Sparrow OC, Iannotti F. Postoperative hematoma: a 5-year survey and identification of avoidable risk factors. Neurosurgery 1994; 35: 1061-4
4. Basali A, Mascha EJ, Kalfas I, Schubert A. Relation between perioperative hypertension and intracranial hemorrhage after craniotomy. Anesthesiology 2000; 93: 48-54
5. Kalfas IH, Little JR. Postoperative hemorrhage: a survey of 4992 intracranial procedures. Neurosurgery 1988; 23: 343-7
6. Rao P, Knaus EE. Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond. J Pharm Pharm Sci 2008; 11: 81s-110s
7. Magni G, La Rosa I, Melillo G, Abeni D, Hernandez H, Rosa G. Intracranial hemorrhage requiring surgery in neurosurgical patients given ketorolac: a case-control study within a cohort (2001-2010). Anesth Analg 2013; 116: 443-7
8. Maund E, McDaid C, Rice S, Wright K, Jenkins B,Woolacott N. Paracetamol and selective and non-selective non-steroidal antiinflammatory drugs for the reduction in morphine-related sideeffects after major surgery: a systematic review. Br J Anaesth 2011; 106: 292-7
9. Scharbert G, Gebhardt K, Sow Z, Duris M, Deusch E, Kozek-Langenecker S. Point-of-care platelet function tests: detection of platelet inhibition induced by nonopioid analgesic drugs. Blood Coagul Fibrinolysis 2007; 18: 775-80
10. Graff J, ArabmotlaghM, Cheung R, Geisslinger G, Harder S. Effects of parecoxib and dipyrone on platelet aggregation in patients undergoing meniscectomy: a double-blind, randomized, parallel-group study. Clin Ther 2007; 29: 438-47
11. Tanskanen P, Kytta J, Randell T. Patient-controlled analgesia with oxycodone in the treatment of postcraniotomy pain. Acta Anaesthesiol Scand 1999; 43: 42-5
12. Innerhofer P, Fries D, Margreiter J, et al. The effects of perioperatively administered colloids and crystalloids on primary plateletmediated hemostasis and clot formation. Anesth Analg 2002; 95: 858-65
13. Sibylle AK. Influence of fluid therapy on the haemostatic system of intensive care patients. Best Pract Res Clin Anaesthesiol 2009; 23: 225-36
14. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotheraputic agents in cancer. In: Macleod CM, ed. Evaluation of Chemotheraputic Agents. Columbia University Press, 1949; 196
15. Gudeman SK, Kishore PR, Miller JD, Girevendulis AK, Lipper MH, Becker DP. The genesis and significance of delayed traumatic intracerebral hematoma. Neurosurgery 1979; 5: 309-13
16. Ekstrom-Jodal B, Haggendal E, Linder LE, Nilsson NJ. The pressure- flowrelations of the canine brain in acute mechanically induced arterial hypertension at different levels of cerebral blood flow. Acta Anaesthesiol Scand 1977; 21: 232-9
17. Willmot M, Leonardi-Bee J, Bath PM. High blood pressure in acute strokeandsubsequent outcome:asystematic review.Hypertension 2004; 43: 18-24
18. Day AL, FriedmanWA, SypertGW, Mickle JP. Successful treatment of the normal perfusion pressure breakthrough syndrome. Neurosurgery 1982; 11: 625-30
19. Fukamachi A, Koizumi H, Nukui H. Postoperative intracerebral hemorrhages: a survey of computed tomographic findings after 1074 intracranial operations. Surg Neurol 1985; 23: 575-80
20. Donovan AL, FlexmanAM, GelbAW. Blood pressuremanagement in stroke. Curr Opin Anaesthesiol 2012; 25: 516-22
21. Goldman L, Ausiello D. Cecil textbook of medicine. In: Ronald V, ed. Arterial Hypertension, 22nd Edn.W.B. Saunders Company, Elsevier Health Sciences, 2003; 346-63
22. VanAken J, StruysM, Verplancke T, de Baerdemaeker L, Caemaert J, Mortier E. Cardiovascular changes during endoscopic third ventriculostomy. Minim Invasive Neurosurg 2003; 46: 198-201
23. McDaid C, Maund E, Rice S, Wright K, Jenkins B, Woolacott N. Paracetamol and selective and non-selective non-steroidal antiinflammatory drugs (NSAIDs) for the reduction of morphinerelated side effects after major surgery: a systematic review. Health Technol Assess 2010; 14: 1-153
24. Zhang Z, Zhao H,Wang C, Han F,Wang G. Lack of preemptive analgesia by intravenous flurbiprofen in thyroid gland surgery: a randomized, double-blind and placebo-controlled clinical trial. Int J Med Sci 2011; 8: 433-8
25. Nishina K, Mikawa K, Shiga M, Takao Y, Maekawa N, Obara H. Diclofenac and flurbiprofen with or without clonidine for postoperative analgesia in children undergoing elective ophthalmological surgery. Paediatr Anaesth 2000; 10: 645-51
26. Sultan A, McQuay HJ, Moore RA, Derry S. Single dose oral flurbiprofen for acute postoperative pain in adults. Cochrane Database Syst Rev 2009; 0: CD007358
27. Umamaheswara Rao GS, Gelb AW. To use or not to use: the dilemma of NSAIDs and craniotomy. Eur J Anaesthesiol 2009; 26: 625-6
28. Flexman AM, Ng JL, Gelb AW. Acute and chronic pain following craniotomy. Curr Opin Anaesthesiol 2010; 23: 551-7
29. Dolmatova EV, Imaev AA, Lubnin AY. "Scheduled" dosing of lornoxicam provides analgesia superior to that provided by "on request" dosing following craniotomy. Eur J Anaesthesiol 2009; 26: 633-7
30. Sebastian J, Hunt K. United Kingdomand Ireland survey of the use of nonsteroidal anti-inflammatory drugs after intracranial surgery. J Neurosurg Anesthesiol 2006; 18: 267
31. Kelly KP, Janssens MC, Ross J, Horn EH. Controversy of non-steroidal anti-inflammatory drugs and intracranial surgery: et ne nos inducas in tentationem?. Br J Anaesth 2011; 107: 302-5
32. Claes Y, Van Hemelrijck J, Van Gerven M, et al. Influence of hydroxyethyl starch on coagulation in patients during the perioperative period. Anesth Analg 1992; 75: 24-30
33. Lee JS, Ahn SW, Song JW, Shim JK, Yoo KJ, Kwak YL. Effect of hydroxyethyl starch 130/0.4 on blood loss and coagulation in patients with recent exposure to dual antiplatelet therapy undergoing off-pump coronary artery bypass graft surgery. Circ J 2011; 75: 2397-402
34. Westphal M, James MF, Kozek-Langenecker S, Stocker R, Guidet B, Van Aken H. Hydroxyethyl starches: different products-different effects. Anesthesiology 2009; 111: 187-202
35. Hartog CS, Reuter D, LoescheW, Hofmann M, Reinhart K. Influence ofhydroxyethyl starch(HES) 130/0.4onhemostasis asmeasuredby viscoelastic device analysis: a systematic review. Intensive Care Med 2011; 37: 1725-37
36. Hartog CS, Kohl M, Reinhart K. A systematic review of third-generation hydroxyethyl starch (HES 130/0.4) in resuscitation: safety not adequately addressed. Anesth Analg 2011; 112: 635-45